Adar Poonawalla: I believe Oxford coronavirus vaccine Covishield will reach masses by 2021 first quarter of
Published
In an interview with IANS, *Adar Poonawalla*, CEO, Serum Institute of India (SII) said as per the arrangement with AstraZeneca, SII will be making one billion doses of Covishield vaccine over the next one year for India and other low-and-middle-income countries (GAVI countries).
"We will start producing a few millions of doses...